ROYAL BANK OF CANADA - AVADEL PHARMACEUTICALS PLC ownership

AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 83 filers reported holding AVADEL PHARMACEUTICALS PLC in Q4 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of AVADEL PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2023$37,000
-82.0%
3,575
-71.3%
0.00%
Q2 2023$205,00012,460
+6130.0%
0.00%
Q2 2022$0
-100.0%
200
-70.0%
0.00%
Q1 2022$4,000
-42.9%
667
-10.3%
0.00%
Q4 2021$7,000
-30.0%
744
-20.7%
0.00%
Q3 2021$10,000
+400.0%
938
+122.8%
0.00%
Q2 2021$2,000
-60.0%
421
-18.4%
0.00%
Q1 2021$5,000
-16.7%
516
-40.6%
0.00%
Q4 2020$6,000
+500.0%
869
-13.1%
0.00%
Q1 2019$1,0000.0%1,000
+300.0%
0.00%
Q4 2018$1,000
-95.5%
250
-95.0%
0.00%
Q3 2018$22,000
-35.3%
5,000
-9.6%
0.00%
Q2 2018$34,000
-41.4%
5,532
-31.2%
0.00%
Q1 2018$58,000
+18.4%
8,038
+33.3%
0.00%
Q4 2017$49,000
-23.4%
6,029
+0.5%
0.00%
Q3 2017$64,000
-3.0%
6,0000.0%0.00%
Q2 2017$66,000
+13.8%
6,000
-1.3%
0.00%
Q1 2017$58,0006,0770.00%
Other shareholders
AVADEL PHARMACEUTICALS PLC shareholders Q4 2020
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 985,210$10,345,0006.10%
Broadfin Capital, LLC 3,568,122$37,465,0005.54%
JW Asset Management, LLC 444,439$4,667,0003.42%
ARMISTICE CAPITAL, LLC 1,688,000$17,724,0002.09%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,655,494$38,383,0001.73%
FALCON POINT CAPITAL, LLC 661,490$6,284,0000.91%
KNOTT DAVID M 158,555$1,665,0000.71%
Perceptive Advisors 3,098,010$32,530,0000.62%
Sio Capital Management, LLC 91,413$960,0000.50%
HEARTLAND ADVISORS INC 700,000$7,350,0000.48%
View complete list of AVADEL PHARMACEUTICALS PLC shareholders